111In-DOTA-hMN-14-800CW

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Name111In-DOTA-hMN-14-800CW

Drug Alias Namedual-labeled anti-CEA humanized antibody (Immunomedics)

ClassificationRadiation-emitting productsBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized

Mechanisms of ActionCarcinoembryonic antigen related cell adhesion molecule 5 antagonists

TargetsCarcinoembryonic antigen related cell adhesion molecule 5

Therapy Area/IndicationsColorectal Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesImmunomedics Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesImmunomedics Inc

Active IndicationsN/A

Inactive IndicationsColorectal Neoplasms

ATC CodeN/A